HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subhash C Prajapati Selected Research

Myeloid-Lymphoid Leukemia Protein

1/2022Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Subhash C Prajapati Research Topics

Disease

2Carcinoma (Carcinomatosis)
06/2016 - 09/2011
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2016
1Glioblastoma (Glioblastoma Multiforme)
06/2016
1Neoplasms (Cancer)
06/2016
1Pain (Aches)
09/2011
1Inflammation (Inflammations)
09/2011

Drug/Important Bio-Agent (IBA)

1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2022
1Myeloid-Lymphoid Leukemia ProteinIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
06/2016
1dipeptidyl peptidase IIIIBA
06/2016
1DNA (Deoxyribonucleic Acid)IBA
06/2016
1Messenger RNA (mRNA)IBA
06/2016
1Peptide Hydrolases (Proteases)FDA Link
09/2011